Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeStance Health (LFST) Non-Current Assets (2021 - 2025)

LifeStance Health (LFST) has disclosed Non-Current Assets for 5 consecutive years, with $1.8 billion as the latest value for Q4 2025.

  • Quarterly Non-Current Assets fell 1.0% to $1.8 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.8 billion through Dec 2025, down 1.0% year-over-year, with the annual reading at $1.8 billion for FY2025, 1.0% down from the prior year.
  • Non-Current Assets for Q4 2025 was $1.8 billion at LifeStance Health, roughly flat from $1.8 billion in the prior quarter.
  • The five-year high for Non-Current Assets was $1.9 billion in Q1 2023, with the low at $1.6 billion in Q2 2021.
  • Average Non-Current Assets over 5 years is $1.8 billion, with a median of $1.8 billion recorded in 2025.
  • The sharpest move saw Non-Current Assets increased 16.87% in 2022, then dropped 4.73% in 2024.
  • Over 5 years, Non-Current Assets stood at $1.7 billion in 2021, then grew by 16.87% to $1.9 billion in 2022, then decreased by 2.91% to $1.9 billion in 2023, then dropped by 4.16% to $1.8 billion in 2024, then fell by 1.0% to $1.8 billion in 2025.
  • According to Business Quant data, Non-Current Assets over the past three periods came in at $1.8 billion, $1.8 billion, and $1.8 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.